1. Home
  2. NKTR vs WRN Comparison

NKTR vs WRN Comparison

Compare NKTR & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • WRN
  • Stock Information
  • Founded
  • NKTR 1990
  • WRN 2006
  • Country
  • NKTR United States
  • WRN Canada
  • Employees
  • NKTR N/A
  • WRN N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • WRN Metal Mining
  • Sector
  • NKTR Health Care
  • WRN Basic Materials
  • Exchange
  • NKTR Nasdaq
  • WRN Nasdaq
  • Market Cap
  • NKTR 238.7M
  • WRN 249.2M
  • IPO Year
  • NKTR 1994
  • WRN N/A
  • Fundamental
  • Price
  • NKTR $1.30
  • WRN $1.21
  • Analyst Decision
  • NKTR Buy
  • WRN Strong Buy
  • Analyst Count
  • NKTR 4
  • WRN 1
  • Target Price
  • NKTR $2.50
  • WRN $4.25
  • AVG Volume (30 Days)
  • NKTR 1.0M
  • WRN 177.7K
  • Earning Date
  • NKTR 11-05-2024
  • WRN 11-01-2024
  • Dividend Yield
  • NKTR N/A
  • WRN N/A
  • EPS Growth
  • NKTR N/A
  • WRN N/A
  • EPS
  • NKTR N/A
  • WRN N/A
  • Revenue
  • NKTR $93,157,000.00
  • WRN N/A
  • Revenue This Year
  • NKTR N/A
  • WRN N/A
  • Revenue Next Year
  • NKTR N/A
  • WRN N/A
  • P/E Ratio
  • NKTR N/A
  • WRN N/A
  • Revenue Growth
  • NKTR 6.17
  • WRN N/A
  • 52 Week Low
  • NKTR $0.41
  • WRN $0.95
  • 52 Week High
  • NKTR $1.93
  • WRN $1.66
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.91
  • WRN 50.05
  • Support Level
  • NKTR $1.26
  • WRN $1.20
  • Resistance Level
  • NKTR $1.42
  • WRN $1.24
  • Average True Range (ATR)
  • NKTR 0.10
  • WRN 0.04
  • MACD
  • NKTR 0.01
  • WRN -0.01
  • Stochastic Oscillator
  • NKTR 61.29
  • WRN 19.23

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

Share on Social Networks: